Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03166709 · ClinicalTrials.gov registry record · NA
Preventing Addiction Related Suicide (PARS)
A NA study of Suicide and Substance-Related Disorders, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 906
- Enrollment target
- 16
- Study locations
NCT03166709: Completed NA study of Suicide and Substance-Related Disorders, sponsored by University of Washington.
NCT03166709 is a NA study of Suicide and Substance-Related Disorders that has completed, run by University of Washington. The registered enrollment target is 906 participants, below the 6,980-participant average among 92 other Suicide trials with a reported enrollment target (87% lower). The trial reports 16 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03166709, a NA study of Suicide and Substance-Related Disorders, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 906 participants
- Enrollment target
- 16
- Study locations
Study Summary
The goal of this study is to evaluate the effectiveness and utility of the investigator's National Institute on Drug Abuse (NIDA) R21 developed "Preventing Addiction Related Suicide" (PARS) program by utilizing a novel stepped wedge design to evaluate PARS as a selected prevention program to increase help-seeking by clients in community addiction treatment.
Primary Outcome
The PARS Help-Seeking Scale consists of 4 items assessing help-seeking behavior in the context of suicidal thoughts or feelings (e.g., calling a crisis/suicide hotline) developed for our pilot trial22 based on prior suicide prevention programs. Participants reported the frequency of past-month help-seeking on behalf of self or others, including friends and family members, from "never" (=0) to "more than 3 times" (=4). Responses were summed to create a score from 0 to 16 with higher numbers indic
Conditions Studied
Interventions
- BEHAVIORAL Preventing Addiction Related Suicide (PARS)
- BEHAVIORAL Intensive Outpatient Program standard session
Study Locations (16)
Washington
- Lakeside-Milam - Auburn
- Lakeside-Milam - Edmonds
- Evergreen Recovery Centers - Everett
- Lakeside-Milam - Everett
- Olalla Recovery Centers - Gig Harbor
- Lakeside-Milam - Issaquah
- Lakeside-Milam - Kirkland
- Northwest Integrated Health - Lakewood
- Evergreen Recovery Centers - Lynnwood
- Lakeside-Milam - Puyallup
- Northwest Integrated Health - Puyallup
- Lakeside-Milam - Renton
- Lakeside-Milam - Seattle
- THS - Seattle
- Lakeside-Milam - Tacoma
- Northwest Integrated Health - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 906 participants |
| Start Date | 2017-10-11 |
| Est. Completion | 2020-05-28 |
| Phase | NA |
What the finished NCT03166709 record still lists
NCT03166709 is an interventional study that assigns participants to a tested intervention. The registered 906 participants enrollment target is mid-sized for trials with a published cap, below the 6,980-participant average among 92 other Suicide trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Preventing Addiction Related Suicide (PARS) is the first listed.
NCT03166709 lists 16 locations in 1 state (Washington).
Frequently Asked Questions
What is clinical trial NCT03166709 about?
NCT03166709 is a clinical study titled "Preventing Addiction Related Suicide (PARS)". The goal of this study is to evaluate the effectiveness and utility of the investigator's National Institute on Drug Abuse (NIDA) R21 developed "Preventing Addiction Related Suicide" (PARS) program by utilizing a novel stepped wedge design to evaluate PARS as a selected prevention program to increas...
What is the current status of trial NCT03166709?
This trial is currently completed. It is a NA study. The enrollment target is 906 participants. The study started on 2017-10-11. Estimated completion is 2020-05-28.
What conditions does trial NCT03166709 study?
This clinical trial studies the following conditions: Suicide, Substance-Related Disorders.
What interventions are being tested in trial NCT03166709?
The interventions under investigation include: Preventing Addiction Related Suicide (PARS) (BEHAVIORAL), Intensive Outpatient Program standard session (BEHAVIORAL).
Who is sponsoring clinical trial NCT03166709?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03166709 being conducted?
This trial has 16 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03166709's enrollment target sits among peer trials
906 15th of 92 higher than 78 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT06216548 · 909 participants · NA
E-PRIME For Children With Medical Complexity
- NCT05769777 · 901 participants · Phase 2
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI